| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.33e-09 | 46 | 22 | 5 | GO:0030020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.62e-06 | 188 | 22 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 3.13e-04 | 891 | 22 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 4.00e-04 | 27 | 22 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 7.54e-04 | 37 | 22 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | snRNA binding | 1.78e-03 | 57 | 22 | 2 | GO:0017069 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 2.24e-03 | 64 | 22 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.38e-03 | 66 | 22 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.38e-03 | 66 | 22 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 3.31e-03 | 78 | 22 | 2 | GO:0003724 | |
| GeneOntologyMolecularFunction | rRNA binding | 3.39e-03 | 79 | 22 | 2 | GO:0019843 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 3.48e-03 | 80 | 22 | 2 | GO:0008186 | |
| GeneOntologyMolecularFunction | transcription factor binding | 8.53e-03 | 753 | 22 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.03e-02 | 140 | 22 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.04e-02 | 417 | 22 | 3 | GO:0140098 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.13e-02 | 147 | 22 | 2 | GO:0042826 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 9.28e-06 | 515 | 21 | 6 | GO:0022613 | |
| GeneOntologyBiologicalProcess | ossification | 1.53e-05 | 562 | 21 | 6 | GO:0001503 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 6.10e-05 | 76 | 21 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | ribosomal small subunit biogenesis | 1.73e-04 | 108 | 21 | 3 | GO:0042274 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 2.32e-04 | 917 | 21 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | establishment of chromosome localization | 2.48e-04 | 122 | 21 | 3 | GO:0051303 | |
| GeneOntologyBiologicalProcess | chromosome localization | 2.99e-04 | 130 | 21 | 3 | GO:0050000 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 3.13e-04 | 132 | 21 | 3 | GO:0000956 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in nucleus | 3.16e-04 | 26 | 21 | 2 | GO:0051457 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 3.33e-04 | 336 | 21 | 4 | GO:0042254 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 4.23e-04 | 358 | 21 | 4 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 4.23e-04 | 358 | 21 | 4 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 4.41e-04 | 362 | 21 | 4 | GO:0000375 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye morphogenesis | 4.81e-04 | 32 | 21 | 2 | GO:0048596 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 4.94e-04 | 373 | 21 | 4 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA processing | 4.97e-04 | 1500 | 21 | 7 | GO:0006396 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.14e-04 | 377 | 21 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.19e-04 | 378 | 21 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.24e-04 | 379 | 21 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | embryonic eye morphogenesis | 6.79e-04 | 38 | 21 | 2 | GO:0048048 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 8.56e-04 | 432 | 21 | 4 | GO:0006401 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 9.52e-04 | 45 | 21 | 2 | GO:0031076 | |
| GeneOntologyBiologicalProcess | maintenance of protein localization in organelle | 1.04e-03 | 47 | 21 | 2 | GO:0072595 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.11e-03 | 204 | 21 | 3 | GO:0048592 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.12e-03 | 464 | 21 | 4 | GO:0141188 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.49e-03 | 502 | 21 | 4 | GO:0008380 | |
| GeneOntologyBiologicalProcess | rRNA processing | 1.57e-03 | 230 | 21 | 3 | GO:0006364 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 1.86e-03 | 244 | 21 | 3 | GO:0022618 | |
| GeneOntologyBiologicalProcess | mitotic metaphase chromosome alignment | 1.98e-03 | 65 | 21 | 2 | GO:0007080 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 2.08e-03 | 254 | 21 | 3 | GO:0071826 | |
| GeneOntologyBiologicalProcess | mRNA processing | 2.10e-03 | 551 | 21 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | ribosomal large subunit biogenesis | 2.48e-03 | 73 | 21 | 2 | GO:0042273 | |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 2.61e-03 | 275 | 21 | 3 | GO:0016072 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 2.69e-03 | 76 | 21 | 2 | GO:0032507 | |
| GeneOntologyCellularComponent | collagen trimer | 2.93e-08 | 88 | 22 | 5 | GO:0005581 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.21e-07 | 12 | 22 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.21e-07 | 12 | 22 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.33e-06 | 21 | 22 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type V trimer | 6.34e-06 | 4 | 22 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | spliceosomal complex | 6.88e-05 | 215 | 22 | 4 | GO:0005681 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 1.56e-04 | 1194 | 22 | 7 | GO:1990904 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.89e-04 | 530 | 22 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | preribosome | 2.26e-04 | 114 | 22 | 3 | GO:0030684 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.65e-04 | 332 | 22 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.06e-04 | 656 | 22 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.13e-04 | 658 | 22 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.41e-03 | 1377 | 22 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | small-subunit processome | 2.87e-03 | 76 | 22 | 2 | GO:0032040 | |
| GeneOntologyCellularComponent | Cajal body | 3.50e-03 | 84 | 22 | 2 | GO:0015030 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 4.63e-03 | 97 | 22 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 4.63e-03 | 97 | 22 | 2 | GO:0005684 | |
| Domain | Collagen | 4.29e-08 | 85 | 22 | 5 | PF01391 | |
| Domain | Collagen | 4.29e-08 | 85 | 22 | 5 | IPR008160 | |
| Domain | Fib_collagen_C | 7.24e-05 | 11 | 22 | 2 | IPR000885 | |
| Domain | NC1_FIB | 7.24e-05 | 11 | 22 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 7.24e-05 | 11 | 22 | 2 | PD002078 | |
| Domain | COLFI | 7.24e-05 | 11 | 22 | 2 | SM00038 | |
| Domain | COLFI | 7.24e-05 | 11 | 22 | 2 | PF01410 | |
| Domain | TSPN | 3.30e-04 | 23 | 22 | 2 | SM00210 | |
| Domain | DEAD_ATP_HELICASE | 6.03e-04 | 31 | 22 | 2 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 6.84e-04 | 33 | 22 | 2 | IPR000629 | |
| Domain | RNA_helicase_DEAD_Q_motif | 8.60e-04 | 37 | 22 | 2 | IPR014014 | |
| Domain | Q_MOTIF | 8.60e-04 | 37 | 22 | 2 | PS51195 | |
| Domain | VWA | 1.96e-03 | 56 | 22 | 2 | PF00092 | |
| Domain | ConA-like_dom | 2.08e-03 | 219 | 22 | 3 | IPR013320 | |
| Domain | Laminin_G | 2.10e-03 | 58 | 22 | 2 | IPR001791 | |
| Domain | DEAD/DEAH_box_helicase_dom | 3.31e-03 | 73 | 22 | 2 | IPR011545 | |
| Domain | DEAD | 3.31e-03 | 73 | 22 | 2 | PF00270 | |
| Domain | - | 3.40e-03 | 74 | 22 | 2 | 3.40.50.410 | |
| Domain | VWFA | 4.15e-03 | 82 | 22 | 2 | PS50234 | |
| Domain | VWA | 4.36e-03 | 84 | 22 | 2 | SM00327 | |
| Domain | VWF_A | 6.00e-03 | 99 | 22 | 2 | IPR002035 | |
| Domain | Helicase_C | 6.97e-03 | 107 | 22 | 2 | PF00271 | |
| Domain | HELICc | 6.97e-03 | 107 | 22 | 2 | SM00490 | |
| Domain | Helicase_C | 7.10e-03 | 108 | 22 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 7.22e-03 | 109 | 22 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.22e-03 | 109 | 22 | 2 | PS51192 | |
| Domain | DEXDc | 7.22e-03 | 109 | 22 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 7.35e-03 | 110 | 22 | 2 | IPR014001 | |
| Domain | - | 1.04e-02 | 746 | 22 | 4 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.61e-02 | 848 | 22 | 4 | IPR027417 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.46e-07 | 44 | 16 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 8.12e-07 | 67 | 16 | 4 | M26999 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.67e-06 | 90 | 16 | 4 | M631 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.60e-05 | 612 | 16 | 6 | MM15547 | |
| Pathway | REACTOME_MRNA_SPLICING | 6.38e-05 | 201 | 16 | 4 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.85e-05 | 212 | 16 | 4 | M14033 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 9.24e-05 | 724 | 16 | 6 | M16843 | |
| Pathway | WP_MRNA_PROCESSING | 1.07e-04 | 451 | 16 | 5 | MM15946 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.20e-04 | 277 | 16 | 4 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.39e-04 | 283 | 16 | 4 | M13087 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.99e-04 | 300 | 16 | 4 | M610 | |
| Pathway | KEGG_SPLICEOSOME | 3.67e-04 | 127 | 16 | 3 | M2044 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.16e-04 | 30 | 16 | 2 | M27772 | |
| Pathway | PID_HIF2PATHWAY | 6.63e-04 | 34 | 16 | 2 | M44 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.65e-04 | 41 | 16 | 2 | MM15538 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.65e-04 | 41 | 16 | 2 | M27778 | |
| Pathway | REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 2.06e-03 | 60 | 16 | 2 | M27613 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.13e-03 | 61 | 16 | 2 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.13e-03 | 61 | 16 | 2 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.28e-03 | 76 | 16 | 2 | MM14573 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.54e-03 | 79 | 16 | 2 | M27643 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.95e-08 | 807 | 22 | 8 | 22681889 | |
| Pubmed | Nuclear Functions of Nucleolin through Global Proteomics and Interactomic Approaches. | 2.92e-08 | 145 | 22 | 5 | 27049334 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 9.33e-08 | 989 | 22 | 8 | 36424410 | |
| Pubmed | 1.05e-07 | 652 | 22 | 7 | 31180492 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.22e-07 | 1024 | 22 | 8 | 24711643 | |
| Pubmed | 1.23e-07 | 390 | 22 | 6 | 17643375 | ||
| Pubmed | 1.93e-07 | 713 | 22 | 7 | 29802200 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.95e-07 | 714 | 22 | 7 | 28302793 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 2.18e-07 | 430 | 22 | 6 | 38172120 | |
| Pubmed | 2.28e-07 | 731 | 22 | 7 | 29298432 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 39191354 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 3.84e-07 | 96 | 22 | 4 | 25948554 | |
| Pubmed | 5.33e-07 | 260 | 22 | 5 | 36199071 | ||
| Pubmed | 6.14e-07 | 847 | 22 | 7 | 35850772 | ||
| Pubmed | 6.39e-07 | 109 | 22 | 4 | 29511296 | ||
| Pubmed | 7.13e-07 | 112 | 22 | 4 | 28416769 | ||
| Pubmed | 1.46e-06 | 134 | 22 | 4 | 24816145 | ||
| Pubmed | 1.55e-06 | 36 | 22 | 3 | 17289661 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 1.58e-06 | 604 | 22 | 6 | 37616343 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.59e-06 | 605 | 22 | 6 | 28977666 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.17e-06 | 148 | 22 | 4 | 32538781 | |
| Pubmed | A novel nuclear structure containing the survival of motor neurons protein. | 2.29e-06 | 4 | 22 | 2 | 8670859 | |
| Pubmed | 2.52e-06 | 655 | 22 | 6 | 35819319 | ||
| Pubmed | Systematic and quantitative assessment of the ubiquitin-modified proteome. | 2.81e-06 | 158 | 22 | 4 | 21906983 | |
| Pubmed | 2.89e-06 | 159 | 22 | 4 | 34537242 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 3.11e-06 | 162 | 22 | 4 | 31363146 | |
| Pubmed | 3.11e-06 | 162 | 22 | 4 | 21890473 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 15494374 | ||
| Pubmed | 3.94e-06 | 172 | 22 | 4 | 26336360 | ||
| Pubmed | 4.44e-06 | 723 | 22 | 6 | 34133714 | ||
| Pubmed | Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. | 4.72e-06 | 180 | 22 | 4 | 21139048 | |
| Pubmed | 5.64e-06 | 421 | 22 | 5 | 34650049 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.86e-06 | 759 | 22 | 6 | 35915203 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 6.29e-06 | 57 | 22 | 3 | 17932509 | |
| Pubmed | 7.06e-06 | 441 | 22 | 5 | 31239290 | ||
| Pubmed | 7.89e-06 | 205 | 22 | 4 | 28927264 | ||
| Pubmed | 7.89e-06 | 205 | 22 | 4 | 27976729 | ||
| Pubmed | 8.94e-06 | 463 | 22 | 5 | 34901782 | ||
| Pubmed | 9.35e-06 | 65 | 22 | 3 | 32521226 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.01e-05 | 1294 | 22 | 7 | 30804502 | |
| Pubmed | 1.04e-05 | 220 | 22 | 4 | 24550385 | ||
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 1.06e-05 | 480 | 22 | 5 | 25437307 | |
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 19808671 | ||
| Pubmed | 1.10e-05 | 223 | 22 | 4 | 20020773 | ||
| Pubmed | 1.19e-05 | 491 | 22 | 5 | 22623428 | ||
| Pubmed | 1.19e-05 | 491 | 22 | 5 | 36273042 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 1.27e-05 | 498 | 22 | 5 | 36634849 | |
| Pubmed | Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. | 1.37e-05 | 9 | 22 | 2 | 16765933 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.89e-05 | 1425 | 22 | 7 | 30948266 | |
| Pubmed | 1.95e-05 | 83 | 22 | 3 | 28794006 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 2.09e-05 | 11 | 22 | 2 | 37142680 | |
| Pubmed | 2.37e-05 | 971 | 22 | 6 | 33306668 | ||
| Pubmed | 2.49e-05 | 90 | 22 | 3 | 30459231 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.49e-05 | 90 | 22 | 3 | 35654790 | |
| Pubmed | 2.72e-05 | 281 | 22 | 4 | 26725010 | ||
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 2.95e-05 | 287 | 22 | 4 | 28712289 | |
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 2.97e-05 | 13 | 22 | 2 | 17765891 | |
| Pubmed | 3.29e-05 | 295 | 22 | 4 | 26209609 | ||
| Pubmed | 3.46e-05 | 14 | 22 | 2 | 21873192 | ||
| Pubmed | 3.49e-05 | 615 | 22 | 5 | 31048545 | ||
| Pubmed | CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1. | 3.52e-05 | 101 | 22 | 3 | 34462429 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 3.74e-05 | 624 | 22 | 5 | 33729478 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 3.80e-05 | 626 | 22 | 5 | 33644029 | |
| Pubmed | 3.95e-05 | 105 | 22 | 3 | 22505724 | ||
| Pubmed | 3.95e-05 | 105 | 22 | 3 | 24625528 | ||
| Pubmed | 3.99e-05 | 15 | 22 | 2 | 28784777 | ||
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 4.14e-05 | 313 | 22 | 4 | 16196087 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 4.35e-05 | 1082 | 22 | 6 | 38697112 | |
| Pubmed | 5.16e-05 | 17 | 22 | 2 | 12388589 | ||
| Pubmed | 5.18e-05 | 115 | 22 | 3 | 17332742 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.55e-05 | 678 | 22 | 5 | 30209976 | |
| Pubmed | 5.71e-05 | 340 | 22 | 4 | 24332808 | ||
| Pubmed | Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47. | 6.03e-05 | 121 | 22 | 3 | 22354994 | |
| Pubmed | 6.03e-05 | 121 | 22 | 3 | 34029587 | ||
| Pubmed | 6.19e-05 | 1153 | 22 | 6 | 29845934 | ||
| Pubmed | 6.48e-05 | 124 | 22 | 3 | 23000965 | ||
| Pubmed | A catalogue of putative HIV-1 protease host cell substrates. | 6.48e-05 | 124 | 22 | 3 | 22944692 | |
| Pubmed | 6.76e-05 | 707 | 22 | 5 | 19738201 | ||
| Pubmed | 6.95e-05 | 711 | 22 | 5 | 33022573 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 7.84e-05 | 1203 | 22 | 6 | 29180619 | |
| Pubmed | Global identification of modular cullin-RING ligase substrates. | 8.16e-05 | 134 | 22 | 3 | 21963094 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.18e-05 | 736 | 22 | 5 | 29676528 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.34e-05 | 135 | 22 | 3 | 28675934 | |
| Pubmed | 8.91e-05 | 138 | 22 | 3 | 30320910 | ||
| Pubmed | 9.05e-05 | 383 | 22 | 4 | 29331416 | ||
| Pubmed | 9.56e-05 | 1247 | 22 | 6 | 27684187 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 9.99e-05 | 1257 | 22 | 6 | 36526897 | |
| Pubmed | 1.05e-04 | 24 | 22 | 2 | 29635000 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.07e-04 | 147 | 22 | 3 | 28977470 | |
| Pubmed | 1.16e-04 | 151 | 22 | 3 | 18457437 | ||
| Pubmed | 1.19e-04 | 152 | 22 | 3 | 16009940 | ||
| Pubmed | 1.21e-04 | 153 | 22 | 3 | 25037231 | ||
| Pubmed | 1.28e-04 | 419 | 22 | 4 | 15635413 | ||
| Pubmed | RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway. | 1.28e-04 | 156 | 22 | 3 | 26170170 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.30e-04 | 1318 | 22 | 6 | 30463901 | |
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 1.35e-04 | 159 | 22 | 3 | 34578187 | |
| Pubmed | 1.35e-04 | 159 | 22 | 3 | 22751105 | ||
| Pubmed | 1.43e-04 | 28 | 22 | 2 | 22178446 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.50e-04 | 1353 | 22 | 6 | 29467282 | |
| Pubmed | Identification of novel transcription-regulating genes expressed during murine molar development. | 1.53e-04 | 29 | 22 | 2 | 22639370 | |
| Interaction | CUL7 interactions | 1.17e-07 | 845 | 22 | 9 | int:CUL7 | |
| Interaction | OBSL1 interactions | 2.04e-07 | 902 | 22 | 9 | int:OBSL1 | |
| Interaction | RPS19 interactions | 2.11e-07 | 639 | 22 | 8 | int:RPS19 | |
| Interaction | SNU13 interactions | 4.68e-07 | 285 | 22 | 6 | int:SNU13 | |
| Interaction | MYCN interactions | 6.32e-07 | 1373 | 22 | 10 | int:MYCN | |
| Interaction | RRP15 interactions | 6.37e-07 | 157 | 22 | 5 | int:RRP15 | |
| Interaction | EBNA1BP2 interactions | 9.90e-07 | 324 | 22 | 6 | int:EBNA1BP2 | |
| Interaction | DDX18 interactions | 1.18e-06 | 334 | 22 | 6 | int:DDX18 | |
| Interaction | ALG13 interactions | 1.36e-06 | 183 | 22 | 5 | int:ALG13 | |
| Interaction | RRS1 interactions | 1.43e-06 | 345 | 22 | 6 | int:RRS1 | |
| Interaction | ZC3H18 interactions | 2.31e-06 | 877 | 22 | 8 | int:ZC3H18 | |
| Interaction | AATF interactions | 2.35e-06 | 376 | 22 | 6 | int:AATF | |
| Interaction | FBL interactions | 3.51e-06 | 639 | 22 | 7 | int:FBL | |
| Interaction | PRC1 interactions | 5.01e-06 | 973 | 22 | 8 | int:PRC1 | |
| Interaction | GLYR1 interactions | 5.02e-06 | 239 | 22 | 5 | int:GLYR1 | |
| Interaction | SNRNP70 interactions | 5.44e-06 | 984 | 22 | 8 | int:SNRNP70 | |
| Interaction | PRPF40A interactions | 6.27e-06 | 446 | 22 | 6 | int:PRPF40A | |
| Interaction | SMN2 interactions | 6.57e-06 | 114 | 22 | 4 | int:SMN2 | |
| Interaction | LSM14A interactions | 7.57e-06 | 260 | 22 | 5 | int:LSM14A | |
| Interaction | SYNCRIP interactions | 7.77e-06 | 721 | 22 | 7 | int:SYNCRIP | |
| Interaction | HNRNPU interactions | 7.90e-06 | 1035 | 22 | 8 | int:HNRNPU | |
| Interaction | RBM39 interactions | 8.30e-06 | 1042 | 22 | 8 | int:RBM39 | |
| Interaction | MTF1 interactions | 8.88e-06 | 123 | 22 | 4 | int:MTF1 | |
| Interaction | DDX23 interactions | 9.55e-06 | 480 | 22 | 6 | int:DDX23 | |
| Interaction | REST interactions | 9.76e-06 | 274 | 22 | 5 | int:REST | |
| Interaction | CIT interactions | 1.06e-05 | 1450 | 22 | 9 | int:CIT | |
| Interaction | CHD3 interactions | 1.07e-05 | 757 | 22 | 7 | int:CHD3 | |
| Interaction | WDR5 interactions | 1.24e-05 | 1101 | 22 | 8 | int:WDR5 | |
| Interaction | BTRC interactions | 1.24e-05 | 775 | 22 | 7 | int:BTRC | |
| Interaction | BMP4 interactions | 1.32e-05 | 136 | 22 | 4 | int:BMP4 | |
| Interaction | RPS9 interactions | 1.42e-05 | 515 | 22 | 6 | int:RPS9 | |
| Interaction | NCL interactions | 1.51e-05 | 798 | 22 | 7 | int:NCL | |
| Interaction | BRIX1 interactions | 1.51e-05 | 300 | 22 | 5 | int:BRIX1 | |
| Interaction | DDX56 interactions | 1.61e-05 | 304 | 22 | 5 | int:DDX56 | |
| Interaction | DOT1L interactions | 1.62e-05 | 807 | 22 | 7 | int:DOT1L | |
| Interaction | MRPS31 interactions | 1.77e-05 | 310 | 22 | 5 | int:MRPS31 | |
| Interaction | HNRNPR interactions | 1.79e-05 | 536 | 22 | 6 | int:HNRNPR | |
| Interaction | RRP1B interactions | 1.88e-05 | 314 | 22 | 5 | int:RRP1B | |
| Interaction | SF3B1 interactions | 2.55e-05 | 571 | 22 | 6 | int:SF3B1 | |
| Interaction | MPHOSPH10 interactions | 3.48e-05 | 174 | 22 | 4 | int:MPHOSPH10 | |
| Interaction | RPL32 interactions | 3.72e-05 | 362 | 22 | 5 | int:RPL32 | |
| Interaction | MECP2 interactions | 3.86e-05 | 1287 | 22 | 8 | int:MECP2 | |
| Interaction | GNL3 interactions | 4.03e-05 | 368 | 22 | 5 | int:GNL3 | |
| Interaction | PML interactions | 4.12e-05 | 933 | 22 | 7 | int:PML | |
| Interaction | NIP7 interactions | 4.23e-05 | 183 | 22 | 4 | int:NIP7 | |
| Interaction | CHD4 interactions | 4.27e-05 | 938 | 22 | 7 | int:CHD4 | |
| Interaction | MIDN interactions | 4.28e-05 | 626 | 22 | 6 | int:MIDN | |
| Interaction | LYAR interactions | 4.30e-05 | 373 | 22 | 5 | int:LYAR | |
| Interaction | KRR1 interactions | 4.63e-05 | 379 | 22 | 5 | int:KRR1 | |
| Interaction | NFIA interactions | 4.70e-05 | 188 | 22 | 4 | int:NFIA | |
| Interaction | SNRNP40 interactions | 4.71e-05 | 637 | 22 | 6 | int:SNRNP40 | |
| Interaction | GNL2 interactions | 5.06e-05 | 386 | 22 | 5 | int:GNL2 | |
| Interaction | MYOD1 interactions | 5.32e-05 | 194 | 22 | 4 | int:MYOD1 | |
| Interaction | RPS2 interactions | 5.60e-05 | 657 | 22 | 6 | int:RPS2 | |
| Interaction | PHIP interactions | 5.64e-05 | 197 | 22 | 4 | int:PHIP | |
| Interaction | NSRP1 interactions | 5.64e-05 | 197 | 22 | 4 | int:NSRP1 | |
| Interaction | RPL9 interactions | 5.85e-05 | 398 | 22 | 5 | int:RPL9 | |
| Interaction | RC3H2 interactions | 6.09e-05 | 667 | 22 | 6 | int:RC3H2 | |
| Interaction | AR interactions | 6.09e-05 | 992 | 22 | 7 | int:AR | |
| Interaction | TRIM66 interactions | 6.59e-05 | 205 | 22 | 4 | int:TRIM66 | |
| Interaction | RC3H1 interactions | 6.62e-05 | 677 | 22 | 6 | int:RC3H1 | |
| Interaction | RNF113A interactions | 7.47e-05 | 692 | 22 | 6 | int:RNF113A | |
| Interaction | RNF4 interactions | 7.48e-05 | 1412 | 22 | 8 | int:RNF4 | |
| Interaction | MEN1 interactions | 7.69e-05 | 1029 | 22 | 7 | int:MEN1 | |
| Interaction | FTSJ3 interactions | 7.71e-05 | 422 | 22 | 5 | int:FTSJ3 | |
| Interaction | KIF23 interactions | 7.78e-05 | 1031 | 22 | 7 | int:KIF23 | |
| Interaction | SOX2 interactions | 7.87e-05 | 1422 | 22 | 8 | int:SOX2 | |
| Interaction | SRP9 interactions | 8.16e-05 | 427 | 22 | 5 | int:SRP9 | |
| Interaction | EED interactions | 8.81e-05 | 1445 | 22 | 8 | int:EED | |
| Interaction | RBM19 interactions | 8.82e-05 | 221 | 22 | 4 | int:RBM19 | |
| Interaction | PIN4 interactions | 9.12e-05 | 81 | 22 | 3 | int:PIN4 | |
| Interaction | ERG interactions | 9.13e-05 | 223 | 22 | 4 | int:ERG | |
| Interaction | DDX21 interactions | 9.16e-05 | 718 | 22 | 6 | int:DDX21 | |
| Interaction | PABPC4 interactions | 9.60e-05 | 442 | 22 | 5 | int:PABPC4 | |
| Interaction | GTPBP4 interactions | 9.70e-05 | 443 | 22 | 5 | int:GTPBP4 | |
| Interaction | RPL18A interactions | 1.01e-04 | 447 | 22 | 5 | int:RPL18A | |
| Interaction | UTP14A interactions | 1.03e-04 | 230 | 22 | 4 | int:UTP14A | |
| Interaction | TRIM31 interactions | 1.09e-04 | 454 | 22 | 5 | int:TRIM31 | |
| Interaction | RPS7 interactions | 1.23e-04 | 466 | 22 | 5 | int:RPS7 | |
| Interaction | DGCR8 interactions | 1.25e-04 | 242 | 22 | 4 | int:DGCR8 | |
| Interaction | RPL4 interactions | 1.29e-04 | 764 | 22 | 6 | int:RPL4 | |
| Interaction | SF3A1 interactions | 1.29e-04 | 471 | 22 | 5 | int:SF3A1 | |
| Interaction | SOX10 interactions | 1.33e-04 | 92 | 22 | 3 | int:SOX10 | |
| Interaction | RSL1D1 interactions | 1.40e-04 | 479 | 22 | 5 | int:RSL1D1 | |
| Interaction | SYK interactions | 1.44e-04 | 251 | 22 | 4 | int:SYK | |
| Interaction | PUM3 interactions | 1.51e-04 | 254 | 22 | 4 | int:PUM3 | |
| Interaction | RPL10A interactions | 1.56e-04 | 490 | 22 | 5 | int:RPL10A | |
| Interaction | SPOP interactions | 1.57e-04 | 491 | 22 | 5 | int:SPOP | |
| Interaction | RPL7 interactions | 1.57e-04 | 491 | 22 | 5 | int:RPL7 | |
| Interaction | REXO4 interactions | 1.67e-04 | 261 | 22 | 4 | int:REXO4 | |
| Interaction | EIF4A3 interactions | 1.69e-04 | 499 | 22 | 5 | int:EIF4A3 | |
| Interaction | NPM3 interactions | 1.70e-04 | 262 | 22 | 4 | int:NPM3 | |
| Interaction | DHX15 interactions | 1.74e-04 | 502 | 22 | 5 | int:DHX15 | |
| Interaction | RPL36 interactions | 1.78e-04 | 504 | 22 | 5 | int:RPL36 | |
| Interaction | H1-1 interactions | 1.83e-04 | 507 | 22 | 5 | int:H1-1 | |
| Interaction | RPL18 interactions | 1.91e-04 | 512 | 22 | 5 | int:RPL18 | |
| Interaction | PRMT8 interactions | 1.91e-04 | 104 | 22 | 3 | int:PRMT8 | |
| Interaction | EPRS1 interactions | 1.93e-04 | 513 | 22 | 5 | int:EPRS1 | |
| Interaction | SF3A2 interactions | 1.99e-04 | 273 | 22 | 4 | int:SF3A2 | |
| Interaction | NPM1 interactions | 2.02e-04 | 1201 | 22 | 7 | int:NPM1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p21 | 8.37e-04 | 89 | 22 | 2 | chr7p21 | |
| GeneFamily | Collagens | 2.58e-08 | 46 | 13 | 4 | 490 | |
| GeneFamily | DEAD-box helicases | 4.04e-04 | 42 | 13 | 2 | 499 | |
| Coexpression | NABA_COLLAGENS | 4.94e-08 | 44 | 22 | 4 | M3005 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 4.60e-07 | 612 | 22 | 7 | M4772 | |
| Coexpression | NABA_CORE_MATRISOME | 2.79e-06 | 275 | 22 | 5 | M5884 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 4.62e-06 | 305 | 22 | 5 | M40025 | |
| Coexpression | NABA_COLLAGENS | 6.20e-06 | 43 | 22 | 3 | MM17060 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 2.16e-05 | 200 | 22 | 4 | M5926 | |
| Coexpression | NABA_CORE_MATRISOME | 6.96e-05 | 270 | 22 | 4 | MM17057 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 1.19e-04 | 115 | 22 | 3 | M7995 | |
| Coexpression | KIM_WT1_TARGETS_8HR_DN | 1.56e-04 | 126 | 22 | 3 | M9948 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 2.59e-04 | 380 | 22 | 4 | M41703 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.72e-04 | 385 | 22 | 4 | M39264 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.50e-06 | 174 | 22 | 4 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 195 | 22 | 4 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 2.55e-06 | 199 | 22 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-06 | 199 | 22 | 4 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_LINC00507_SLN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-05 | 162 | 22 | 3 | b59a0081e285cdf33de56e8b523fe0e446a198f1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.21e-05 | 166 | 22 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | tumor_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 8.15e-05 | 173 | 22 | 3 | 934550c0290fb1058f353d97dba92757aeb2075e | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-05 | 177 | 22 | 3 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-05 | 181 | 22 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.63e-05 | 183 | 22 | 3 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 183 | 22 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 183 | 22 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.63e-05 | 183 | 22 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.79e-05 | 184 | 22 | 3 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 9.79e-05 | 184 | 22 | 3 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 185 | 22 | 3 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.94e-05 | 185 | 22 | 3 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 185 | 22 | 3 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.94e-05 | 185 | 22 | 3 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.94e-05 | 185 | 22 | 3 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 22 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 22 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.03e-04 | 187 | 22 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 187 | 22 | 3 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-5|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.09e-04 | 191 | 22 | 3 | f2fe8fe316e449f452075aa37d5e31917221a335 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-04 | 191 | 22 | 3 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 192 | 22 | 3 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 192 | 22 | 3 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.13e-04 | 193 | 22 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 193 | 22 | 3 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 193 | 22 | 3 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 193 | 22 | 3 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 193 | 22 | 3 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 194 | 22 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 194 | 22 | 3 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.14e-04 | 194 | 22 | 3 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 194 | 22 | 3 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 194 | 22 | 3 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 194 | 22 | 3 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.16e-04 | 195 | 22 | 3 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.16e-04 | 195 | 22 | 3 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 196 | 22 | 3 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 196 | 22 | 3 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 197 | 22 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 197 | 22 | 3 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 197 | 22 | 3 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 197 | 22 | 3 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 197 | 22 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.22e-04 | 198 | 22 | 3 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature2_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 198 | 22 | 3 | 89e25687b614525548279e5fa293c66f5c4abec3 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 198 | 22 | 3 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 5'-GW_trimst-2|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 198 | 22 | 3 | 677816ea6d1706d99b7757d43b6b375276b25639 | |
| ToppCell | 11.5-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 1.22e-04 | 198 | 22 | 3 | fe08709d043d927988b1bb262c766b0b572fc927 | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 198 | 22 | 3 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 198 | 22 | 3 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | 11.5-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 1.22e-04 | 198 | 22 | 3 | 5c606d881f151404287d9b43c9490e9bb486ef54 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 198 | 22 | 3 | 81c4c5377d0901ee9594424f08b0e4101686c850 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 198 | 22 | 3 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.22e-04 | 198 | 22 | 3 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 198 | 22 | 3 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 198 | 22 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | distal-mesenchymal-Mesothelial-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | 431bf719ee5cce4c9e8b6b405819b67e98fad3ca | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.22e-04 | 198 | 22 | 3 | 23783572c22c24d9fb8e14dc1f3852d2094157df | |
| ToppCell | distal-mesenchymal-Mesothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 198 | 22 | 3 | 52e3cb45472dd6db31ae533e9ea0c3b550f11496 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.23e-04 | 199 | 22 | 3 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 1.23e-04 | 199 | 22 | 3 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-04 | 199 | 22 | 3 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.23e-04 | 199 | 22 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.23e-04 | 199 | 22 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-04 | 199 | 22 | 3 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.23e-04 | 199 | 22 | 3 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | CV-Moderate-2|CV / Virus stimulation, Condition and Cluster | 1.23e-04 | 199 | 22 | 3 | 2d98424a5247e87f98095c11fb945289092a9d75 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial-RG|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | b3775715b66aee18cff469bf3dbe9c305671c6d6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 9069e8d3bcc5f44baa00f2abb6cffd87586c3eab | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 429028c3112d279b26abf3296e01b1884b4b7fcb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.25e-04 | 200 | 22 | 3 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-04 | 200 | 22 | 3 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-04 | 200 | 22 | 3 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-03 | 101 | 22 | 2 | 6523c314166dcf66c3ed13c02ca4b886b068e5b8 | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 1.63e-03 | 122 | 22 | 2 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-03 | 125 | 22 | 2 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.96e-03 | 134 | 22 | 2 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-03 | 136 | 22 | 2 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 2.01e-03 | 136 | 22 | 2 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 137 | 22 | 2 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-03 | 138 | 22 | 2 | 096c0c8ed396a27d29cca94e2e15099b64129c57 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 139 | 22 | 2 | c300f953ff9c5e820ff16bcd9942d279b37b79db | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 139 | 22 | 2 | 95b19d7459d9b54162cf01d278462245d34802d5 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 2.13e-03 | 140 | 22 | 2 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.22e-03 | 143 | 22 | 2 | 9bfb3674c8f011b9cf928b522777b8d54478db8d | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-03 | 144 | 22 | 2 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-03 | 144 | 22 | 2 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-03 | 144 | 22 | 2 | ea174487f8ade90deb33b964a7f7e65062606565 | |
| ToppCell | RV-05._Cytoplasmic_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.32e-03 | 146 | 22 | 2 | 25c61342a8acc3a7681365a7710598e07e72990e | |
| Computational | Neighborhood of KPNB1 | 1.34e-06 | 73 | 13 | 4 | GNF2_KPNB1 | |
| Computational | Neighborhood of HDAC1 | 6.91e-06 | 110 | 13 | 4 | GNF2_HDAC1 | |
| Computational | Neighborhood of APEX1 | 1.63e-04 | 92 | 13 | 3 | GNF2_APEX1 | |
| Computational | Neighborhood of BUB3 | 2.57e-04 | 277 | 13 | 4 | MORF_BUB3 | |
| Computational | Neighborhood of DAP3 | 3.49e-04 | 119 | 13 | 3 | GNF2_DAP3 | |
| Computational | Neighborhood of RAD23A | 6.12e-04 | 348 | 13 | 4 | MORF_RAD23A | |
| Computational | Neighborhood of RFC4 | 7.01e-04 | 151 | 13 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of TDG | 7.86e-04 | 35 | 13 | 2 | GNF2_TDG | |
| Computational | Neighborhood of ELAC2 | 1.36e-03 | 46 | 13 | 2 | GNF2_ELAC2 | |
| Computational | Neighborhood of PRKDC | 1.39e-03 | 191 | 13 | 3 | MORF_PRKDC | |
| Computational | Neighborhood of DENR | 1.67e-03 | 51 | 13 | 2 | GNF2_DENR | |
| Computational | Neighborhood of DEK | 2.15e-03 | 58 | 13 | 2 | GNF2_DEK | |
| Computational | Neighborhood of SMC1L1 | 2.45e-03 | 62 | 13 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of DDX5 | 2.69e-03 | 65 | 13 | 2 | GCM_DDX5 | |
| Computational | RNA splicing. | 2.69e-03 | 65 | 13 | 2 | MODULE_183 | |
| Computational | Neighborhood of TERF1 | 2.86e-03 | 67 | 13 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of EIF3S2 | 2.86e-03 | 246 | 13 | 3 | MORF_EIF3S2 | |
| Computational | Neighborhood of CBFB | 3.11e-03 | 70 | 13 | 2 | GCM_CBFB | |
| Computational | Neighborhood of RBBP6 | 3.11e-03 | 70 | 13 | 2 | GNF2_RBBP6 | |
| Computational | Neighborhood of NPM1 | 3.29e-03 | 72 | 13 | 2 | GNF2_NPM1 | |
| Computational | Neighborhood of DEK | 3.49e-03 | 264 | 13 | 3 | MORF_DEK | |
| Computational | Genes in the cancer module 331. | 3.57e-03 | 75 | 13 | 2 | MODULE_331 | |
| Computational | Neighborhood of SOD1 | 4.04e-03 | 278 | 13 | 3 | MORF_SOD1 | |
| Computational | Neighborhood of HDAC2 | 4.12e-03 | 280 | 13 | 3 | MORF_HDAC2 | |
| Computational | Neighborhood of RRM1 | 6.50e-03 | 102 | 13 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of PTPN11 | 7.26e-03 | 108 | 13 | 2 | MORF_PTPN11 | |
| Drug | NSC-14083 | 1.48e-06 | 210 | 22 | 5 | CID000005297 | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 3.38e-05 | 195 | 22 | 4 | 5287_UP | |
| Drug | Pirenperone [ 75444-65-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 3.52e-05 | 197 | 22 | 4 | 2455_UP | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.59e-05 | 198 | 22 | 4 | 2878_UP | |
| Drug | strontium ranelate | 5.47e-05 | 77 | 22 | 3 | CID006918182 | |
| Drug | AC1L2HAX | 5.85e-05 | 12 | 22 | 2 | CID000020942 | |
| Drug | Stallimycin | 6.13e-05 | 80 | 22 | 3 | CID000003115 | |
| Drug | cyclooctane | 1.20e-04 | 17 | 22 | 2 | CID000009266 | |
| Drug | ticlopidine | 1.30e-04 | 103 | 22 | 3 | CID000005472 | |
| Drug | chromomycin A3 | 1.30e-04 | 103 | 22 | 3 | CID000656673 | |
| Drug | 351A | 1.68e-04 | 20 | 22 | 2 | CID000122144 | |
| Drug | DMSe | 2.71e-04 | 132 | 22 | 3 | CID000020796 | |
| Drug | deamino-NAD | 3.08e-04 | 27 | 22 | 2 | CID000004480 | |
| Drug | PCR 4099 | 3.15e-04 | 139 | 22 | 3 | CID000002806 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 3.32e-04 | 28 | 22 | 2 | CID011650719 | |
| Drug | isodesmosine | 4.62e-04 | 33 | 22 | 2 | CID000013811 | |
| Drug | Sirius red | 5.20e-04 | 35 | 22 | 2 | CID005486818 | |
| Drug | GK-101 | 5.50e-04 | 36 | 22 | 2 | CID000161853 | |
| Drug | AC1NRA5C | 6.07e-04 | 174 | 22 | 3 | CID005287709 | |
| Drug | AC1MRIIV | 6.46e-04 | 39 | 22 | 2 | CID003518584 | |
| Drug | cytosine | 7.70e-04 | 441 | 22 | 4 | CID000000597 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 7.72e-04 | 189 | 22 | 3 | 5208_DN | |
| Drug | PD123177 | 7.86e-04 | 43 | 22 | 2 | CID000114899 | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.96e-04 | 191 | 22 | 3 | 2250_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 7.96e-04 | 191 | 22 | 3 | 2857_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.20e-04 | 193 | 22 | 3 | 4690_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; HL60; HG-U133A | 8.20e-04 | 193 | 22 | 3 | 2015_DN | |
| Drug | NC-4 | 8.23e-04 | 44 | 22 | 2 | CID006420119 | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 2891_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 8.32e-04 | 194 | 22 | 3 | 2293_DN | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 6247_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 1532_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A | 8.45e-04 | 195 | 22 | 3 | 4508_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 2329_DN | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 5680_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 2210_DN | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 4802_DN | |
| Drug | Cyproterone acetate [427-51-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 3545_UP | |
| Drug | monastrol; Down 200; 20uM; MCF7; HG-U133A | 8.58e-04 | 196 | 22 | 3 | 614_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 4728_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 8.58e-04 | 196 | 22 | 3 | 7225_UP | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 7462_DN | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6517_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 8.70e-04 | 197 | 22 | 3 | 1071_DN | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 2868_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6063_DN | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5564_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 5576_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 2328_UP | |
| Drug | Probucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 4666_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 7505_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 8.70e-04 | 197 | 22 | 3 | 6829_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4750_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 3067_UP | |
| Drug | 5155877; Down 200; 10uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 6569_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 4669_DN | |
| Drug | Tropine [120-29-6]; Down 200; 28.4uM; PC3; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 5790_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 3511_DN | |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 8.83e-04 | 198 | 22 | 3 | 5470_UP | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 5664_DN | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2921_UP | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 3101_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 2298_UP | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 7452_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 6775_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 8.96e-04 | 199 | 22 | 3 | 3879_DN | |
| Drug | Madecassol | 8.99e-04 | 46 | 22 | 2 | CID000108062 | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 5603_DN | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.09e-04 | 200 | 22 | 3 | 4505_DN | |
| Disease | social communication impairment | 2.60e-04 | 32 | 22 | 2 | EFO_0005427 | |
| Disease | triglyceride measurement, response to diuretic | 2.93e-04 | 34 | 22 | 2 | EFO_0004530, GO_0036270 | |
| Disease | cortical thickness | 1.17e-03 | 1113 | 22 | 5 | EFO_0004840 | |
| Disease | Parkinson disease | 1.68e-03 | 321 | 22 | 3 | MONDO_0005180 | |
| Disease | colorectal cancer, hormone replacement therapy | 1.95e-03 | 88 | 22 | 2 | EFO_0003961, MONDO_0005575 | |
| Disease | Psychotic Disorders | 2.56e-03 | 101 | 22 | 2 | C0033975 | |
| Disease | Intellectual Disability | 4.29e-03 | 447 | 22 | 3 | C3714756 | |
| Disease | Global developmental delay | 4.39e-03 | 133 | 22 | 2 | C0557874 | |
| Disease | cognitive decline measurement | 5.42e-03 | 486 | 22 | 3 | EFO_0007710 | |
| Disease | eosinophilic esophagitis | 6.52e-03 | 163 | 22 | 2 | EFO_0004232 | |
| Disease | reading and spelling ability | 6.75e-03 | 166 | 22 | 2 | EFO_0005301 | |
| Disease | Malignant neoplasm of breast | 7.56e-03 | 1074 | 22 | 4 | C0006142 | |
| Disease | Neoplasm Invasiveness | 8.23e-03 | 184 | 22 | 2 | C0027626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKKKNGRNRGGKANN | 41 | Q9BX10 | |
| GKGKKLNIGGGGLGY | 646 | Q86XP3 | |
| GRGRGGKRGNQSGKN | 71 | P22087 | |
| GQQQAGGKKKAEGGG | 206 | Q00839 | |
| NKNKSGKNQFNRGGG | 691 | Q00839 | |
| GGNVGGKRKADGYNQ | 566 | O43390 | |
| NSNEGKQKKRGGGGG | 626 | Q9NVP1 | |
| GDEGKKGSKGNQGQR | 551 | Q2UY09 | |
| GSMGLKNGAGNGAKG | 81 | O00512 | |
| KNGAGNGAKGKGKRE | 86 | O00512 | |
| GKGHGKEQTGRGSKG | 991 | Q9NX05 | |
| KKGDKGNQGEKGIQG | 696 | Q96P44 | |
| GGGNTNFGRGRKGQK | 101 | P05997 | |
| KGRTGAKGAKGYQGQ | 1251 | Q8IZC6 | |
| GGLQQQKQQKGRGMG | 91 | Q9Y4Z0 | |
| KGNIGLGGVKGQKGS | 181 | A6NHN0 | |
| KNAKKGQGGAGAGDD | 176 | P46781 | |
| GNGNGGGKGKQAAPK | 16 | Q9ULQ0 | |
| KIEKGVGGNNGGNGN | 16 | P08047 | |
| GGKRKGGLGGKMNSG | 331 | Q15050 | |
| GLQNKNRGGANGKGR | 456 | Q9ULD9 | |
| GDLKGGNKAAIQGNG | 156 | O94901 | |
| QGKRGKKSAGCGGGG | 71 | Q15672 | |
| GGGKGNRGKDDRGKA | 141 | B1AL88 |